Carl Domino’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$960K Sell
15,055
-2,115
-12% -$123K 1.17% 45
2017
Q2
$957K Sell
17,170
-1,930
-10% -$105K 1.11% 45
2017
Q1
$1.04M Sell
19,100
-2,510
-12% -$138K 1.14% 46
2016
Q4
$1.26M Buy
+21,610
New +$1.18M 1.35% 35
2015
Q2
Sell
-2,690
Closed -$174K 156
2015
Q1
$174K Sell
2,690
-3,940
-59% -$247K 0.13% 151
2014
Q4
$391K Sell
6,630
-960
-13% -$54.1K 0.21% 95
2014
Q3
$388K Sell
7,590
-3,840
-34% -$192K 0.21% 94
2014
Q2
$554K Buy
11,430
+2,904
+34% +$143K 0.28% 84
2014
Q1
$443K Sell
8,526
-204
-2% -$10.9K 0.23% 91
2013
Q4
$464K Buy
8,730
+1,465
+20% +$74.6K 0.25% 90
2013
Q3
$336K Sell
7,265
-12
-0.2% -$527 0.19% 98
2013
Q2
$325K Buy
+7,277
New +$316K 0.18% 100

Other funds holding BMY

Carl Domino's BMY Position: Q3 2017 in Review

Carl Domino reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q3 2017, selling an estimated $123K and leaving 15,055 shares worth $960K. The position accounts for 1.17% of the portfolio, ranked #45.

Carl Domino first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.26M in Q4 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Carl Domino held 15,055 shares of Bristol-Myers Squibb worth $960K as of Q3 2017.
  • Carl Domino sold 2,115 Bristol-Myers Squibb shares in Q3 2017, an estimated $123K.
  • Bristol-Myers Squibb made up 1.17% of Carl Domino's portfolio in Q3 2017, its #45 holding.
  • Carl Domino first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
  • Carl Domino's Bristol-Myers Squibb position peaked at $1.26M in Q4 2016.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.